Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Pharmacotherapy Rounds: When Old Drugs Require New Guidelines.

DeVane CL.

Pharmacotherapy. 2019 Jan;39(1):4-6. doi: 10.1002/phar.2206. Epub 2019 Jan 13. No abstract available.

PMID:
30637792
2.

Anticoagulation Research and Awareness-A Cross-Therapeutic Need.

DeVane CL.

Pharmacotherapy. 2018 Jun;38(6):586-587. doi: 10.1002/phar.2123. No abstract available.

PMID:
29932469
3.

Pharmacotherapy Rounds: Can We Improve the Fate of Unused Drugs?

DeVane CL.

Pharmacotherapy. 2018 Mar;38(3):306-308. doi: 10.1002/phar.2098. No abstract available.

PMID:
29575172
4.

Opioid Use and Abuse and Neonatal Abstinence Syndrome.

DeVane CL.

Pharmacotherapy. 2017 Jul;37(7):779-780. doi: 10.1002/phar.1969. No abstract available.

PMID:
28726245
5.

Honoring Pharmacotherapy's Editorial Board.

DeVane CL.

Pharmacotherapy. 2016 Jan;36(1):11-2. doi: 10.1002/phar.1688. No abstract available.

PMID:
26799346
6.

The Art and Science of Reviewing the Pharmacotherapy Literature.

DeVane CL.

Pharmacotherapy. 2015 Nov;35(11):981-2. doi: 10.1002/phar.1661. No abstract available.

PMID:
26598089
7.

Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.

McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J.

Drug Alcohol Depend. 2015 Nov 1;156:29-37. doi: 10.1016/j.drugalcdep.2015.08.013. Epub 2015 Aug 25.

8.

Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence.

McRae-Clark AL, Baker NL, Sonne SC, DeVane CL, Wagner A, Norton J.

J Subst Abuse Treat. 2015 Oct;57:70-4. doi: 10.1016/j.jsat.2015.05.002. Epub 2015 May 7.

9.

An epidemic of opioid prescriptions.

DeVane CL.

Pharmacotherapy. 2015 Mar;35(3):241-2. doi: 10.1002/phar.1571. Review. No abstract available.

PMID:
25809174
10.

In her own words: Jean Nappi, ACCP President, 1994-1995.

Nappi J, DeVane CL.

Pharmacotherapy. 2015 Jan;35(1):4-7. doi: 10.1002/phar.1539. No abstract available.

PMID:
25630409
11.

Parents and mentors may be gone but they are never forgotten.

DeVane CL.

Pharmacotherapy. 2015 Jan;35(1):1-3. doi: 10.1002/phar.1541. No abstract available.

PMID:
25630408
12.

Basic science and the Ebola virus infection epidemic.

DeVane CL.

Pharmacotherapy. 2014 Nov;34(11):1115-7. doi: 10.1002/phar.1520. No abstract available.

PMID:
25382095
13.

Essential tools for designing pharmacotherapy.

DeVane CL.

Pharmacotherapy. 2014 Feb;34(2):112-3. doi: 10.1002/phar.1405. No abstract available.

PMID:
24523096
14.

Behind the cover at Pharmacotherapy.

DeVane CL.

Pharmacotherapy. 2014 Feb;34(2):109-11. doi: 10.1002/phar.1402. No abstract available.

PMID:
24523095
15.

Pig fat, pork bellies, and portly appearance.

DeVane CL.

Pharmacotherapy. 2013 Dec;33(12):1297-8. doi: 10.1002/phar.1389. No abstract available.

PMID:
24302198
16.

Marijuana use in America: whither are we bound?

DeVane CL.

Pharmacotherapy. 2013 Oct;33(10):1009-11. doi: 10.1002/phar.1363. No abstract available.

PMID:
24092499
17.

What evidence is required for drug exposure to be causally associated with adverse events? The case for case reports published in Pharmacotherapy.

DeVane CL.

Pharmacotherapy. 2013 Feb;33(2):115-7. doi: 10.1002/phar.1249. No abstract available.

PMID:
23386592
18.

Pro-inflammatory biomakers in depression: treatment with venlafaxine.

Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H, Sinacore J, Devane CL.

World J Biol Psychiatry. 2009;10(4):313-23. doi: 10.3109/15622970802573246.

PMID:
19921973
19.

P-glycoprotein inhibition potentiates the behavioural and neurochemical actions of risperidone in rats.

Pacchioni AM, Gabriele A, Donovan JL, DeVane CL, See RE.

Int J Neuropsychopharmacol. 2010 Sep;13(8):1067-77. doi: 10.1017/S1461145709990782. Epub 2009 Oct 19.

PMID:
19835667
20.

The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.

Markowitz JS, DeVane CL, Ramamoorthy S, Zhu HJ.

Pharmazie. 2009 Feb;64(2):123-5.

PMID:
19322953
21.

Aripiprazole brain concentration is altered in P-glycoprotein deficient mice.

Wang JS, Zhu HJ, Donovan JL, Yuan HJ, Markowitz JS, Geesey ME, Devane CL.

Schizophr Res. 2009 May;110(1-3):90-4. doi: 10.1016/j.schres.2009.01.011. Epub 2009 Feb 23.

PMID:
19239981
22.

Antipsychotic drugs inhibit the function of breast cancer resistance protein.

Wang JS, Zhu HJ, Markowitz JS, Donovan JL, Yuan HJ, Devane CL.

Basic Clin Pharmacol Toxicol. 2008 Oct;103(4):336-41. doi: 10.1111/j.1742-7843.2008.00298.x.

23.

Fluvoxamine.

Devane CL.

Neuropsychiatr Dis Treat. 2005 Dec;1(4):287. No abstract available.

24.

Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.

Zhu HJ, Patrick KS, Yuan HJ, Wang JS, Donovan JL, DeVane CL, Malcolm R, Johnson JA, Youngblood GL, Sweet DH, Langaee TY, Markowitz JS.

Am J Hum Genet. 2008 Jun;82(6):1241-8. doi: 10.1016/j.ajhg.2008.04.015. Epub 2008 May 15.

25.

Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein.

Wang JS, Zhu HJ, Gibson BB, Markowitz JS, Donovan JL, DeVane CL.

Biol Pharm Bull. 2008 Feb;31(2):231-4.

26.

Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.

LeVasseur NL, Zhu HJ, Markowitz JS, DeVane CL, Patrick KS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 1;862(1-2):140-9. Epub 2007 Dec 4.

27.

The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.

Wang JS, Newport DJ, Stowe ZN, Donovan JL, Pennell PB, DeVane CL.

Drug Metab Rev. 2007;39(4):723-46. Review.

PMID:
18058331
28.

Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.

Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.

Eur J Pharmacol. 2008 Jan 14;578(2-3):148-58. Epub 2007 Oct 5.

29.

A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma.

Zhu HJ, Wang JS, Patrick KS, Donovan JL, DeVane CL, Markowitz JS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15;858(1-2):91-5. Epub 2007 Aug 19.

30.
31.

Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.

Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, Knight BT, Gibson BB, Viguera AC, Owens MJ, Nemeroff CB, Stowe ZN.

Am J Psychiatry. 2007 Aug;164(8):1214-20.

PMID:
17671284
32.

Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.

Risch SC, Horner MD, McGurk SR, Palecko S, Markowitz JS, Nahas Z, DeVane CL.

Schizophr Res. 2007 Jul;93(1-3):131-5. Epub 2007 Mar 27.

PMID:
17391930
33.

Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics.

Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, Markowitz JS.

Clin Pharmacol Ther. 2007 Mar;81(3):346-53.

34.

A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study.

Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R.

J Child Adolesc Psychopharmacol. 2006 Dec;16(6):687-98.

PMID:
17201613
35.

Modafinil and cocaine interactions.

Malcolm R, Swayngim K, Donovan JL, DeVane CL, Elkashef A, Chiang N, Khan R, Mojsiak J, Myrick DL, Hedden S, Cochran K, Woolson RF.

Am J Drug Alcohol Abuse. 2006;32(4):577-87.

PMID:
17127546
36.

Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization.

Zhu HJ, Wang JS, Donovan JL, DeVane CL, Gibson BB, Markowitz JS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):351-4. Epub 2006 Sep 1.

PMID:
16949894
37.

Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.

Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, DeVane CL.

Neuropsychopharmacology. 2007 Apr;32(4):757-64. Epub 2006 Aug 23.

38.

Antidepressant-drug interactions are potentially but rarely clinically significant.

DeVane CL.

Neuropsychopharmacology. 2006 Aug;31(8):1594-604; discussion 1614-5. Review.

39.

Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.

Wang JS, Zhu HJ, Markowitz JS, Donovan JL, DeVane CL.

Psychopharmacology (Berl). 2006 Sep;187(4):415-23. Epub 2006 Jun 30.

PMID:
16810505
40.

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.

DeVane CL, Stowe ZN, Donovan JL, Newport DJ, Pennell PB, Ritchie JC, Owens MJ, Wang JS.

J Psychopharmacol. 2006 Jul;20(4 Suppl):54-9. Review.

PMID:
16785271
41.

The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine.

Zhu HJ, Wang JS, DeVane CL, Williard RL, Donovan JL, Middaugh LD, Gibson BB, Patrick KS, Markowitz JS.

Drug Metab Dispos. 2006 Jul;34(7):1116-21. Epub 2006 Apr 18.

PMID:
16621932
42.

Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.

Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL.

J Pharmacol Exp Ther. 2006 May;317(2):850-7. Epub 2006 Jan 26.

PMID:
16439618
43.
44.

Antidepressants in amniotic fluid: another route of fetal exposure.

Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, DeVane CL, Stowe ZN.

Am J Psychiatry. 2006 Jan;163(1):145-7.

PMID:
16390902
45.

Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice.

Wang JS, DeVane CL, Gibson BB, Donovan JL, Markowitz JS, Zhu HJ.

Psychopharmacology (Berl). 2006 Jan;183(4):490-9. Epub 2005 Nov 9.

PMID:
16283256
46.

Placental passage of tricyclic antidepressants.

Loughhead AM, Stowe ZN, Newport DJ, Ritchie JC, DeVane CL, Owens MJ.

Biol Psychiatry. 2006 Feb 1;59(3):287-90. Epub 2005 Nov 2.

PMID:
16271264
47.

Effects of St John's wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women: a pilot study.

Donovan JL, DeVane CL, Lewis JG, Wang JS, Ruan Y, Chavin KD, Markowitz JS.

Phytother Res. 2005 Oct;19(10):901-6.

PMID:
16261523
48.

Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F(2 alpha), a biomarker for in-vivo lipid peroxidation.

Donovan JL, DeVane CL, Chavin KD, Oates JC, Njoku C, Patrick KS, Fiorini RN, Markowitz JS.

J Pharm Pharmacol. 2005 Oct;57(10):1365-9.

PMID:
16259767
49.

Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression.

Devane CL, Chiao E, Franklin M, Kruep EJ.

Am J Manag Care. 2005 Oct;11(12 Suppl):S344-53. Review.

50.

Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder.

Risch SC, Horner MD, McGurk SR, Palecko S, Markowitz JS, Nahas Z, DeVane CL.

Int J Neuropsychopharmacol. 2006 Oct;9(5):603-5. Epub 2005 Oct 4.

PMID:
16202177

Supplemental Content

Loading ...
Support Center